The BRIDGE Program: A Revolutionary Approach to Early-Onset Cancer Care
The rising incidence of cancer among younger adults is a pressing issue that demands innovative solutions. The BRIDGE Program, a multidisciplinary initiative at The Ohio State University Comprehensive Cancer Center, is at the forefront of this revolution. By focusing on age as a defining factor, rather than tumor type alone, the program aims to integrate clinical care with research, patient support, and policy exploration to better serve this distinct and growing population.
In an interview with Targeted Oncology, W. Kimryn Rathmell, MD, PhD, CEO of The Ohio State University Comprehensive Cancer Center, discussed the key findings of the AACR abstract and how they informed the clinical priorities and structure of the BRIDGE Program.
The study, presented at the 2026 American Association for Cancer Research (AACR) Annual Meeting, found that nearly 60% of cancers diagnosed in adults younger than 50 fall into categories that are already potentially screen-detectable. This highlights a significant gap between existing screening practices and emerging epidemiologic realities. The key takeaway for oncologists, according to Dr. Rathmell, is that most cancers have the opportunity to be detected early, which can guide the approach to this problem.
The BRIDGE Program's unique approach encompasses all patients in the age group of 20 to 50, including those with adolescent and young adult (AYA) tumors. By focusing on age cohort rather than individual cancers, the program provides a comprehensive approach to care, research, and support. This includes disease experts who understand the unique ramifications of being a young person with cancer, as well as common tools and support for patients with diverse needs.
The five core pillars of the BRIDGE Program are research, comprehensive care, patient and family support, community engagement, and program sustainability. These pillars allow for a cohesive approach to care, research, and support, with a focus on open doors for people to contribute and overlap in a positive way.
Dr. Rathmell highlighted the importance of recognizing outliers, such as patients with cancer at a much younger age, as they provide valuable insights. The program's impact on patients and clinicians is already evident, with early outcomes showing appreciation for the attention and coordination of care, as well as recognition of the unique nature of early-onset cancer. The program's ability to bridge gaps between different treatment teams and provide a multidisciplinary approach is a key strength.
The BRIDGE Program's success in its early stages is a testament to the importance of addressing the unique needs of younger adults with cancer. By focusing on age as a defining factor, the program is revolutionizing the way we approach early-onset cancer care, and its impact on patients and clinicians is already evident. As the program continues to evolve, it will undoubtedly play a crucial role in shaping the future of cancer care for younger adults.
